LENZ - LENZ Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
LENZ Therapeutics, Inc. Common Stock
IPO Date: June 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $127.88M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.79 | 3.69%
Avg Daily Range (30 D): $0.19 | 3.80%
Avg Daily Range (90 D): $0.24 | 4.01%
Institutional Daily Volume
Avg Daily Volume: .46M
Avg Daily Volume (30 D): .61M
Avg Daily Volume (90 D): .72M
Trade Size
Avg Trade Size (Sh.): 73
Avg Trade Size (Sh.) (30 D): 100
Avg Trade Size (Sh.) (90 D): 89
Institutional Trades
Total Institutional Trades: 612
Avg Institutional Trade: $1.69M
Avg Institutional Trade (30 D): $.61M
Avg Institutional Trade (90 D): $.89M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.55M
Avg Closing Trade (30 D): $.61M
Avg Closing Trade (90 D): $.89M
Avg Closing Volume: 80.22K
 
News
Jun 7, 2026 @ 11:30 PM
LENZ Therapeutics Announces Everest Medicines Acqu...
Source: Lenz Therapeutics
May 11, 2026 @ 5:00 PM
Presbyopia Market to Witness Accelerated Growth at...
Source: Delveinsight
Mar 24, 2026 @ 2:13 PM
Why Lenz Therapeutics Stock Crashed Today
Source: Rich Smith
Jul 31, 2025 @ 1:10 PM
Lenz (LENZ) Q2 Revenue Jumps 604%
Source: Jesterai
Jun 10, 2024 @ 12:00 PM
LENZ Therapeutics to Host Key Opinion Leader Event...
Source: LENZ Therapeutics, Inc.
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-1.02 $-1.32 $-1.2
Diluted EPS $-1.02 $-1.32 $-1.2
Revenue $5.49M $1.9M $1.59M
Gross Profit $5.21M $.83M
Net Income / Loss $-31.92M $-41.49M $-35.9M
Operating Income / Loss $-34.17M $-44.14M $-38.46M
Cost of Revenue $.28M $1.08M
Net Cash Flow $-.56M $-.41M $-.22M
PE Ratio    
Splits
Mar 22, 2024 1:7